文献速递产科母胎医学

慢性组织细胞性绒毛间隙炎:临床结局与胎盘生长因子及子宫动脉多普勒的关系

Chronic histiocytic intervillositis of the placenta: clinical outcomes and relationships with circulating placental growth factor and uterine artery Doppler waveforms.
PubMed 文献 · Am J Obstet Gynecol · 2026-02-03

单中心历史队列研究纳入66例病理确诊慢性组织细胞性绒毛间隙炎的妊娠,仅20%足月分娩,26%发生死胎。孕16–23周低胎盘生长因子对死胎敏感度高(0.95)而特异度有限(0.50),子宫动脉多普勒异常与后续死胎风险无关。

要点

  • 慢性组织细胞性绒毛间隙炎妊娠不良结局率高,仅20%足月分娩,26%死胎。
  • 孕16–23周低胎盘生长因子对死胎敏感度0.95,阴性似然比0.10,利于排除。
  • 孕16–23周子宫动脉多普勒异常与后续死胎风险无关。

核心结论

  • 慢性组织细胞性绒毛间隙炎妊娠不良结局率高,包括极端早产及严重胎儿生长受限相关死胎。
  • 孕早期中段母体循环低胎盘生长因子可能是慢性组织细胞性绒毛间隙炎的早期生物标志物。
  • 当慢性组织细胞性绒毛间隙炎为唯一胎盘病理诊断时,子宫动脉多普勒波形信息价值较低。

研究设计与样本

  • 单中心历史队列研究,纳入2010年3月至2025年8月病理确诊胎盘慢性组织细胞性绒毛间隙炎的妊娠。
  • 共66例患者符合纳入标准,平均 maternal age 33.2 ± 5.1 岁。
  • 胎盘生长因子检测自2017年起可获取。
  • 异常子宫动脉多普勒定义为平均搏动指数>95百分位或双侧舒张早期切迹。
  • 胎盘生长因子低于同孕龄第10百分位视为异常。

主要发现

  • 仅13例妊娠(20%)足月分娩(>37周),17例(26%)发生死胎,44例婴儿(67%)存活出院。
  • 活产儿中50%出生体重低于第10百分位(平均出生体重1341 ± 1009 g)。
  • 胎盘生长因子低于第10百分位见于几乎所有病例,包括全部17例死胎妊娠。
  • 孕16–23周低胎盘生长因子对死胎敏感度0.95(95%CI 0.77–0.99),特异度0.50(95%CI 0.18–0.82),阳性似然比1.9(95%CI 0.82–4.40),阴性似然比0.10(95%CI 0.02–0.65)。
  • 45例接受检测患者中27例(60%)子宫动脉平均搏动指数正常;18例子宫动脉多普勒异常者中7例(39%)合并母体血管灌注不良。

关键数值与推荐

  • 异常子宫动脉多普勒:平均搏动指数>95百分位或双侧舒张早期切迹。
  • 异常胎盘生长因子:低于同孕龄第10百分位。
  • 孕16–23周低胎盘生长因子对死胎的阴性似然比0.10(95%CI 0.02–0.65),提示较强的排除性能。

临床怎么用

  • 孕早期中段系列胎盘生长因子检测可能有助于评估慢性组织细胞性绒毛间隙炎妊娠的预后。
  • 胎盘生长因子检测或可用于既往胎盘诊断慢性组织细胞性绒毛间隙炎者的后续妊娠监测。
  • 子宫动脉多普勒在慢性组织细胞性绒毛间隙炎为唯一胎盘病理时信息价值有限。

局限性

  • 单中心历史队列研究,样本量66例。
  • 胎盘生长因子检测仅自2017年起可获取。
  • 子宫动脉多普勒特异度95%CI下限与上限报告为0.05–0.25,数值范围异常,解读需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic histiocytic intervillositis is a rare placental disorder characterized by maternal macrophage accumulation within the intervillous space of the placenta. Local cytokine release by these immune cells mediates injury to the developing placental villi, resulting in a spectrum of early pregnancy loss, severe fetal growth restriction, or stillbirth. Despite good evidence that chronic histiocytic intervillositis begins in early pregnancy, no effective risk assessment tools exist to predict pregnancy outcomes and, thus, appropriate fetal surveillance. OBJECTIVE: This study aimed to explore the role of serial circulating placental growth factor and uterine artery Doppler waveform assessments beginning in the early second trimester in pregnancies that were found to be complicated by chronic histiocytic intervillositis of the placenta. STUDY DESIGN: Single-center historical cohort study of pregnancy outcomes in pregnancies with a confirmed pathologic diagnosis of placental chronic histiocytic intervillositis between March 2010 and August 2025. Maternal demographics, uterine artery Doppler waveform indices, circulating placental growth factor levels, and maternal and perinatal outcomes were abstracted from electronic medical record systems. Placental growth factor testing was available from 2017 onward. Abnormal uterine artery Doppler was defined as a mean pulsatility index of >95th percentile or bilateral early diastolic notching. Placental growth factor levels of <10th percentile for gestational age were considered abnormal. Diagnostic test characteristics (with 95% confidence intervals), including sensitivity, specificity, and likelihood ratios, were estimated to assess the performance of low circulating placental growth factor and uterine artery Doppler waveforms for subsequent stillbirth. RESULTS: Overall, 66 patients met the inclusion criteria, with a mean maternal age of 33.2 ± 5.1 years. Only 13 pregnancies (20%) were delivered at term (>37 weeks of gestation). Stillbirth occurred in 17 pregnancies (26%), and 44 infants (67%) were discharged alive. Among live births, 50% had birthweights below the 10th percentile (birth weight: mean ± standard deviation, 1341 ± 1009 g). Placental growth factor was below the 10th percentile in nearly all cases, including all 17 pregnancies resulting in a stillbirth. Between 16 and 23 weeks of gestation, low placental growth factor showed high sensitivity for stillbirth (0.95 [95% confidence interval, 0.77-0.99]) but limited specificity (0.50 [95% confidence interval, 0.18-0.82]), with a modest positive likelihood ratio (1.9 [95% confidence interval, 0.82-4.40]) and a low negative likelihood ratio (0.10 [95% confidence interval, 0.02-0.65]), indicating strong rule-out performance. Of note, 27 of 45 tested patients (60%) had normal uterine artery mean pulsatility index values. Of the 18 patients with abnormal uterine artery Dopplers, 7 (39%) had coexistent maternal vascular malperfusion. Abnormal uterine artery Doppler at 16 to 23 weeks of gestation was not associated with the subsequent risk of stillbirth (likelihood ratio, 1.22 [95% confidence interval, 0.19-7.61]); sensitivity, 0.22 [95% confidence interval, 0.05-0.50]; and specificity, 0.81 [95% confidence interval, 0.05-0.25]). CONCLUSION: Pregnancies complicated by chronic histiocytic intervillositis have a high rate of adverse pregnancy outcomes, including extreme preterm delivery and associated stillbirth due to severe fetal growth restriction. Low circulating maternal placental growth factor level in the early second trimester of pregnancy may serve as a useful early biomarker for evolving chronic histiocytic intervillositis. In contrast, uterine artery Doppler waveforms were less informative when chronic histiocytic intervillositis was the only placental pathology diagnosis. Serial placental growth factor tests in the early second trimester of pregnancy may be a useful prognostic marker in subsequent pregnancies after a placental diagnosis of chronic histiocytic intervillositis, including the potential to provide in vivo evidence of the effects of various proposed drug regimens to prevent chronic histiocytic intervillositis recurrence.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Bartels HC, Chandran AR, Parks WT, et al. Chronic histiocytic intervillositis of the placenta: clinical outcomes and relationships with circulating placental growth factor and uterine artery Doppler waveforms. Am J Obstet Gynecol. 2026. PMID: 41638616. doi:10.1016/j.ajog.2026.01.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。